Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-08

Clinical Trial Update: Tamsulosin vs Placebo to Prevent Postoperative Urinary Retention in Female Pelvic Reconstructive Surgery [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial comparing tamsulosin to placebo for preventing postoperative urinary retention in female pelvic reconstructive surgery, completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tamsulosin (tamsulosin)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Urinary Retention, Lower Urinary Tract Symptoms | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-11-08